(1S,6R)-3-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-3,9-diazabicyclo[4.2.1]nonan-4-one;dihydrochloride
C16H25Cl2N3O2 — CID 154925030
Data last refreshed: (MolForge compound catalog, from PubChem)
About (1S,6R)-3-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-3,9-diazabicyclo[4.2.1]nonan-4-one;dihydrochloride
(1S,6R)-3-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-3,9-diazabicyclo[4.2.1]nonan-4-one;dihydrochloride (PubChem CID 154925030) has the molecular formula C16H25Cl2N3O2 and a molecular weight of 362.30 g/mol. Its IUPAC name is (1S,6R)-3-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-3,9-diazabicyclo[4.2.1]nonan-4-one;dihydrochloride.
Molecular Properties
| Compound Name | (1S,6R)-3-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-3,9-diazabicyclo[4.2.1]nonan-4-one;dihydrochloride |
|---|---|
| PubChem CID | 154925030 |
| Molecular Formula | C16H25Cl2N3O2 |
| Molecular Weight | 362.30 g/mol |
| Exact Mass | 361.13 |
| IUPAC Name | (1S,6R)-3-[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]-3,9-diazabicyclo[4.2.1]nonan-4-one;dihydrochloride |
| SMILES | COc1c(C)cnc(CN2C[C@@H]3CC[C@H](CC2=O)N3)c1C.Cl.Cl |
| InChI | InChI=1S/C16H23N3O2.2ClH/c1-10-7-17-14(11(2)16(10)21-3)9-19-8-13-5-4-12(18-13)6-15(19)20;;/h7,12-13,18H,4-6,8-9H2,1-3H3;2*1H/t12-,13+;;/m1../s1 |
| InChIKey | TYMQTOZRFFESDK-VAALMUBNSA-N |
| XLogP | 2.40 |
| TPSA | 54.46 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 23 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 362.30 |
| LogP ≤ 5 | 2.40 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154925030 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.